Observational Multicenter Study in Patients Receiving Chemotherapy and Amivantamab for Metastatic Non-small Cell Lung Cancer

NCT07563205 · clinicaltrials.gov ↗

RECRUITING

Status

100

Enrollment

OTHER

Sponsor class

Conditions

Non-Small Cell Lung Cancer
Non Small Cell Lung Cancer Metastatic
Non Small Cell Lung Cancer NSCLC
Non Small Cell Lung Carcinoma
NSCLC
EGFR
EGFR Exon 20 Insertion Mutation
EGFR Exon 19 Deletion Mutation
EGFR Exon 21 Mutation

Sponsor

GFPC Investigation